{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:51:46Z","timestamp":1791273106710,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K14610"],"award-info":[{"award-number":["23K14610"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K19348"],"award-info":[{"award-number":["24K19348"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11883"],"award-info":[{"award-number":["24K11883"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11949"],"award-info":[{"award-number":["25K11949"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.1038\/s41416-026-03552-5","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:33:58Z","timestamp":1784313238000},"page":"1328-1341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High KPNA2 expression predicts poor prognosis in pathological T4 colorectal cancer by importing c-Myc into the nucleus to suppress p53-dependent p21 expression"],"prefix":"10.1038","volume":"135","author":[{"given":"Gendensuren","family":"Dorjkhorloo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilguun","family":"Erkhem-Ochir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Okami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuma","family":"Shioi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Komine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhisa","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Osone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8912-6977","authenticated-orcid":false,"given":"Atsushi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3284-4796","authenticated-orcid":false,"given":"Takehiko","family":"Yokobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7243-6960","authenticated-orcid":false,"given":"Hiroshi","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"3552_CR1","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1245\/s10434-018-6462-1","volume":"25","author":"MR Weiser","year":"2018","unstructured":"Weiser MR. AJCC 8th edition: colorectal cancer. Ann Surg Oncol. 2018;25:1454\u20135.","journal-title":"Ann Surg Oncol"},{"key":"3552_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ijc.28676","volume":"135","author":"P Snaebjornsson","year":"2014","unstructured":"Snaebjornsson P, Coupe VM, Jonasson L, Meijer GA, van Grieken NC, Jonasson JG. pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd\u2019s local peritoneal involvement revisited. Int J Cancer. 2014;135:467\u201378.","journal-title":"Int J Cancer"},{"key":"3552_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4132\/jptm.2015.02.05","volume":"49","author":"JH Kim","year":"2015","unstructured":"Kim JH, Bae JM, Oh HJ, Lee HS, Kang GH. Pathologic factors associated with prognosis after adjuvant chemotherapy in stage II\/III microsatellite-unstable colorectal cancers. J Pathol Transl Med. 2015;49:118\u201328.","journal-title":"J Pathol Transl Med"},{"key":"3552_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1245\/s10434-017-6037-6","volume":"25","author":"CEL Klaver","year":"2018","unstructured":"Klaver CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, Tanis PJ, van der Bilt JDW, et al. Locally advanced colorectal cancer: true peritoneal tumor penetration is associated with peritoneal metastases. Ann Surg Oncol. 2018;25:212\u201320.","journal-title":"Ann Surg Oncol"},{"key":"3552_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cjp2.258","volume":"8","author":"A Alnabulsi","year":"2022","unstructured":"Alnabulsi A, Wang T, Pang W, Ionescu M, Craig SG, Humphries MP, et al. Identification of a prognostic signature in colorectal cancer using combinatorial algorithm-driven analysis. J Pathol Clin Res. 2022;8:245\u201356.","journal-title":"J Pathol Clin Res"},{"key":"3552_CR6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3389\/fonc.2019.01284","volume":"9","author":"BA Alves Martins","year":"2019","unstructured":"Alves Martins BA, de Bulhoes GF, Cavalcanti IN, Martins MM, de Oliveira PG, Martins AMA. Biomarkers in colorectal cancer: the role of translational proteomics research. Front Oncol. 2019;9:1284.","journal-title":"Front Oncol"},{"key":"3552_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41571-024-00943-6","volume":"21","author":"CJM Williams","year":"2024","unstructured":"Williams CJM, Peddle AM, Kasi PM, Seligmann JF, Roxburgh CS, Middleton GW, et al. Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response. Nat Rev Clin Oncol. 2024;21:839\u201351.","journal-title":"Nat Rev Clin Oncol"},{"key":"3552_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1101\/gad.348226.120","volume":"35","author":"J Li","year":"2021","unstructured":"Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 2021;35:787\u2013820.","journal-title":"Genes Dev"},{"key":"3552_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas NetworkComprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330\u20137.","journal-title":"Nature"},{"key":"3552_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2023.1079129","volume":"10","author":"L Niu","year":"2023","unstructured":"Niu L, Liu L, Cai J. A novel strategy for precise prognosis management and treatment option in colon adenocarcinoma with TP53 mutations. Front Surg. 2023;10:1079129.","journal-title":"Front Surg"},{"key":"3552_CR11","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42:946\u201367.","journal-title":"Cancer Cell"},{"key":"3552_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29:946\u201360.","journal-title":"Cell Death Differ"},{"key":"3552_CR13","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3389\/fonc.2020.01744","volume":"10","author":"L Therachiyil","year":"2020","unstructured":"Therachiyil L, Haroon J, Sahir F, Siveen KS, Uddin S, Kulinski M, et al. Dysregulated phosphorylation of p53, autophagy and stemness attributes the mutant p53 harboring colon cancer cells impaired sensitivity to oxaliplatin. Front Oncol. 2020;10:1744.","journal-title":"Front Oncol"},{"key":"3552_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3892\/ol.2017.5579","volume":"13","author":"L Yu","year":"2017","unstructured":"Yu L, Wang G, Zhang Q, Gao L, Huang R, Chen Y, et al. Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer. Oncol Lett. 2017;13:1194\u2013200.","journal-title":"Oncol Lett"},{"key":"3552_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.12.013","volume":"331","author":"A Christiansen","year":"2013","unstructured":"Christiansen A, Dyrskjot L. The functional role of the novel biomarker karyopherin alpha 2 (KPNA2) in cancer. Cancer Lett. 2013;331:18\u201323.","journal-title":"Cancer Lett"},{"key":"3552_CR16","first-page":"851","volume":"30","author":"M Sakai","year":"2010","unstructured":"Sakai M, Sohda M, Miyazaki T, Suzuki S, Sano A, Tanaka N, et al. Significance of karyopherin-alpha 2 (KPNA2) expression in esophageal squamous cell carcinoma. Anticancer Res. 2010;30:851\u20136.","journal-title":"Anticancer Res"},{"key":"3552_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21873\/cdp.10404","volume":"5","author":"S Otake","year":"2025","unstructured":"Otake S, Ogushi K, Dorjkhorloo G, Yokobori T, Nishi A, Kuwano H, et al. High tumoral KPNA2 expression is a potential biomarker for poor prognosis in advanced neuroblastoma patients. Cancer Diagn Progn. 2025;5:1\u20137.","journal-title":"Cancer Diagn Progn"},{"key":"3552_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.pan.2017.04.011","volume":"17","author":"N Kubo","year":"2017","unstructured":"Kubo N, Araki K, Altan B, Hoshino K, Ishii N, Tsukagoshi M, et al. Enhanced karyopherin-alpha2 expression is associated with carcinogenesis in patients with intraductal papillary mucinous neoplasms. Pancreatology. 2017;17:611\u20136.","journal-title":"Pancreatology"},{"key":"3552_CR19","doi-asserted-by":"publisher","first-page":"42159","DOI":"10.18632\/oncotarget.15020","volume":"8","author":"M Tsukagoshi","year":"2017","unstructured":"Tsukagoshi M, Araki K, Yokobori T, Altan B, Suzuki H, Kubo N, et al. Overexpression of karyopherin-alpha2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins. Oncotarget. 2017;8:42159\u201372.","journal-title":"Oncotarget"},{"key":"3552_CR20","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/carcin\/bgt214","volume":"34","author":"B Altan","year":"2013","unstructured":"Altan B, Yokobori T, Mochiki E, Ohno T, Ogata K, Ogawa A, et al. Nuclear karyopherin-alpha2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis. 2013;34:2314\u201321.","journal-title":"Carcinogenesis"},{"key":"3552_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18632\/oncotarget.13863","volume":"8","author":"LN Zhou","year":"2017","unstructured":"Zhou LN, Tan Y, Li P, Zeng P, Chen MB, Tian Y, et al. Prognostic value of increased KPNA2 expression in some solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8:303\u201314.","journal-title":"Oncotarget"},{"key":"3552_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/jso.24114","volume":"113","author":"T Takada","year":"2016","unstructured":"Takada T, Tsutsumi S, Takahashi R, Ohsone K, Tatsuki H, Suto T, et al. KPNA2 over-expression is a potential marker of prognosis and therapeutic sensitivity in colorectal cancer patients. J Surg Oncol. 2016;113:213\u20137.","journal-title":"J Surg Oncol"},{"key":"3552_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10616-025-00808-5","volume":"77","author":"Q Feng","year":"2025","unstructured":"Feng Q, Song Q, Han B, Deng Z, Yu R, Liang J. KPNA2 promotes lung adenocarcinoma progression by inducing glycolysis-assisted MYC nuclear translocation. Cytotechnology. 2025;77:158.","journal-title":"Cytotechnology"},{"key":"3552_CR24","doi-asserted-by":"publisher","first-page":"39594","DOI":"10.1074\/jbc.M508425200","volume":"280","author":"SF Tseng","year":"2005","unstructured":"Tseng SF, Chang CY, Wu KJ, Teng SC. Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1. J Biol Chem. 2005;280:39594\u2013600.","journal-title":"J Biol Chem"},{"key":"3552_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0456-x","volume":"17","author":"E Drucker","year":"2019","unstructured":"Drucker E, Holzer K, Pusch S, Winkler J, Calvisi DF, Eiteneuer E, et al. Karyopherin alpha2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer. Cell Commun Signal. 2019;17:159.","journal-title":"Cell Commun Signal"},{"key":"3552_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0014-4827(02)00020-4","volume":"283","author":"AL Gartel","year":"2003","unstructured":"Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res. 2003;283:17\u201321.","journal-title":"Exp Cell Res"},{"key":"3552_CR27","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.921087","volume":"26","author":"C Shi","year":"2020","unstructured":"Shi C, Sun L, Liu S, Zhang E, Song Y. Overexpression of karyopherin subunit alpha 2 (KPNA2) predicts unfavorable prognosis and promotes bladder cancer tumorigenicity via the P53 pathway. Med Sci Monit. 2020;26:e921087.","journal-title":"Med Sci Monit"},{"key":"3552_CR28","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.3892\/or.2016.4750","volume":"35","author":"L Gao","year":"2016","unstructured":"Gao L, Yu L, Li CM, Li Y, Jia BL, Zhang B. Karyopherin alpha2 induces apoptosis in tongue squamous cell carcinoma CAL-27 cells through the p53 pathway. Oncol Rep. 2016;35:3357\u201362.","journal-title":"Oncol Rep"},{"key":"3552_CR29","first-page":"179","volume":"40","author":"F Lin","year":"2018","unstructured":"Lin F, Gao L, Su Z, Cao X, Zhan Y, Li Y, et al. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation. Oncol Rep. 2018;40:179\u201394.","journal-title":"Oncol Rep"},{"key":"3552_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00428-024-03790-z","volume":"486","author":"M Osakabe","year":"2025","unstructured":"Osakabe M, Yamada N, Sugimoto R, Uesugi N, Nakao E, Honda M, et al. The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer. Virchows Arch. 2025;486:333\u201341.","journal-title":"Virchows Arch"},{"key":"3552_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"3552_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10549-016-3893-x","volume":"158","author":"MA Aleskandarany","year":"2016","unstructured":"Aleskandarany MA, Green AR, Ashankyty I, Elmouna A, Diez-Rodriguez M, Nolan CC, et al. Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer. Breast Cancer Res Treat. 2016;158:287\u201395.","journal-title":"Breast Cancer Res Treat"},{"key":"3552_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.256","volume":"4","author":"L Huang","year":"2013","unstructured":"Huang L, Wang HY, Li JD, Wang JH, Zhou Y, Luo RZ, et al. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Cell Death Dis. 2013;4:e745.","journal-title":"Cell Death Dis"},{"key":"3552_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117736","volume":"253","author":"M Duan","year":"2020","unstructured":"Duan M, Hu F, Li D, Wu S, Peng N. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-kappaB signaling and c-Myc nuclear translocation in vitro. Life Sci. 2020;253:117736.","journal-title":"Life Sci"},{"key":"3552_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-018-0861-9","volume":"37","author":"J Li","year":"2018","unstructured":"Li J, Liu Q, Liu Z, Xia Q, Zhang Z, Zhang R, et al. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc. J Exp Clin Cancer Res. 2018;37:194.","journal-title":"J Exp Clin Cancer Res"},{"key":"3552_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.onc.1206145","volume":"22","author":"S Wu","year":"2003","unstructured":"Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene. 2003;22:351\u201360.","journal-title":"Oncogene"},{"key":"3552_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac177","volume":"1","author":"M Nishimura","year":"2022","unstructured":"Nishimura M, Takizawa Y, Nozawa K, Kurumizaka H. Structural basis for p53 binding to its nucleosomal target DNA sequence. PNAS Nexus. 2022;1:pgac177.","journal-title":"PNAS Nexus"},{"key":"3552_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06566-4","volume":"23","author":"S Yan","year":"2025","unstructured":"Yan S, Zhan F, He Y, Zhu Y, Ma Z. p53 in colorectal cancer: from a master player to a privileged therapy target. J Transl Med. 2025;23:684.","journal-title":"J Transl Med"},{"key":"3552_CR39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jare.2024.06.009","volume":"70","author":"M Khakwani","year":"2025","unstructured":"Khakwani M, Ji XY, Khattak S, Sun YC, Yao K, Zhang L. Targeting colorectal cancer at the level of nuclear pore complex. J Adv Res. 2025;70:423\u201344.","journal-title":"J Adv Res"},{"key":"3552_CR40","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1042\/BJ20120150","volume":"443","author":"KM Wagstaff","year":"2012","unstructured":"Wagstaff KM, Sivakumaran H, Heaton SM, Harrich D, Jans DA. Ivermectin is a specific inhibitor of importin alpha\/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem J. 2012;443:851\u20136.","journal-title":"Biochem J"},{"key":"3552_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41388-021-02116-6","volume":"41","author":"F Han","year":"2022","unstructured":"Han F, Zhang L, Liao S, Zhang Y, Qian L, Hou F, et al. The interaction between S100A2 and KPNA2 mediates NFYA nuclear import and is a novel therapeutic target for colorectal cancer metastasis. Oncogene. 2022;41:657\u201370.","journal-title":"Oncogene"},{"key":"3552_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-4-92","volume":"4","author":"R Ravizza","year":"2004","unstructured":"Ravizza R, Gariboldi MB, Passarelli L, Monti E. Role of the p53\/p21 system in the response of human colon carcinoma cells to Doxorubicin. BMC Cancer. 2004;4:92.","journal-title":"BMC Cancer"},{"key":"3552_CR43","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.18632\/oncotarget.7685","volume":"7","author":"S Chung","year":"2016","unstructured":"Chung S, Kijima K, Kudo A, Fujisawa Y, Harada Y, Taira A, et al. Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor. Oncotarget. 2016;7:18171\u201382.","journal-title":"Oncotarget"},{"key":"3552_CR44","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcb.20218","volume":"93","author":"H Zhao","year":"2004","unstructured":"Zhao H, Yu J, Peltier CP, Davie JR. Elevated expression of the estrogen receptor prevents the down-regulation of p21Waf1\/Cip1 in hormone dependent breast cancer cells. J Cell Biochem. 2004;93:619\u201328.","journal-title":"J Cell Biochem"},{"key":"3552_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jcp.22078","volume":"224","author":"S Mandal","year":"2010","unstructured":"Mandal S, Davie JR. Estrogen regulated expression of the p21 Waf1\/Cip1 gene in estrogen receptor positive human breast cancer cells. J Cell Physiol. 2010;224:28\u201332.","journal-title":"J Cell Physiol"},{"key":"3552_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1006\/bbrc.1999.1062","volume":"261","author":"G Fiorelli","year":"1999","unstructured":"Fiorelli G, Picariello L, Martineti V, Tonelli F, Brandi ML. Functional estrogen receptor beta in colon cancer cells. Biochem Biophys Res Commun. 1999;261:521\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"3552_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1006\/bbrc.2000.2444","volume":"270","author":"N Arai","year":"2000","unstructured":"Arai N, Strom A, Rafter JJ, Gustafsson JA. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun. 2000;270:425\u201331.","journal-title":"Biochem Biophys Res Commun"},{"key":"3552_CR48","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/s41388-017-0040-z","volume":"37","author":"D Ghannam-Shahbari","year":"2018","unstructured":"Ghannam-Shahbari D, Jacob E, Kakun RR, Wasserman T, Korsensky L, Sternfeld O, et al. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Oncogene. 2018;37:2213\u201324.","journal-title":"Oncogene"},{"key":"3552_CR49","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00432-017-2512-5","volume":"143","author":"D Jeong","year":"2017","unstructured":"Jeong D, Kim H, Ban S, Oh S, Ji S, Kim D, et al. Karyopherin alpha-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer. J Cancer Res Clin Oncol. 2017;143:2493\u2013503.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3552_CR50","doi-asserted-by":"publisher","first-page":"8664","DOI":"10.1200\/JCO.2005.01.6071","volume":"23","author":"DJ Sargent","year":"2005","unstructured":"Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2005;23:8664\u201370.","journal-title":"J Clin Oncol"},{"key":"3552_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10039-y","volume":"22","author":"KM Kim","year":"2022","unstructured":"Kim KM, Ahn AR, Park HS, Jang KY, Moon WS, Kang MJ, et al. Clinical significance of p53 protein expression and TP53 variation status in colorectal cancer. BMC Cancer. 2022;22:940.","journal-title":"BMC Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03552-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03552-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03552-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:01:30Z","timestamp":1791270090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03552-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["3552"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03552-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Gunma University Hospital (approval number: HS2023-056). Informed consent was obtained using the opt-out method owing to the retrospective nature of this study. All mouse experiments were approved by the Animal Care and Use Committee of Gunma University (Protocol No. 23-038) and conducted in accordance with the guidelines of the Institute for Laboratory Animal Research at Gunma University.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}